Rapid Dose Therapeutics Corp.
DOSE
CNSX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.48M | -3.89M | -4.25M | -3.97M | -3.72M |
| Total Depreciation and Amortization | 208.60K | 174.10K | 267.00K | 343.90K | 412.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.67M | 1.89M | 1.93M | 1.46M | 1.17M |
| Change in Net Operating Assets | 919.90K | 986.40K | 250.90K | 62.90K | 86.80K |
| Cash from Operations | -690.60K | -838.00K | -1.80M | -2.10M | -2.05M |
| Capital Expenditure | -4.00K | -4.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 600.00 | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.40K | -4.00K | -- | -- | -- |
| Total Debt Issued | 122.90K | 33.80K | 157.70K | 1.22M | 2.55M |
| Total Debt Repaid | -383.80K | -412.90K | -412.10K | -596.60K | -1.45M |
| Issuance of Common Stock | 809.40K | 1.39M | 2.66M | 2.19M | 1.90M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 377.60K | -- | -94.90K | -94.90K | -153.80K |
| Cash from Financing | 666.80K | 740.00K | 1.71M | 2.00M | 2.11M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -2.70K | -- | -- | 0.00 | 0.00 |
| Net Change in Cash | -29.90K | -101.90K | -92.20K | -96.50K | 61.70K |